What is Parkinson’s disease and what are the new treatments?

What is Parkinson’s disease and what are the new treatments?

New research and technology have allowed advancements in the way patients can take their medication.

Metabolic driver of Parkinson's disease offers new target for treatment

Researchers have identified a key enzyme driving forms of Parkinson's disease, and have shown how blocking it restores normal function in animal and cell models, offering a promising new drug target for the condition.

Researchers identify the key metabolic drivers of Parkinson’s disease

Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment and offering fresh hope to millions of patients worldwide A key pathological hallmark of Parkinson’s disease is the accumulation of Lewy bodies—abnormal aggregates of the protein alpha-synuclein—within neurons. The exact cause of neuronal degeneration remains unknown…

Parkinson’s disease is a neurological condition that affects the movement and is characterized by symptoms such as tremors, stiffness and slowness. This progressive disease is caused by the degeneration of nerve cells in part of the brain called black substance, which is responsible for the production of dopamine, a crucial neurotransmitter for motor control. The...